Global Geriatric Medicines Market Size, Status and Forecast 2025


Report ID : RNR-228289 Category : Pharma Healthcare Published Date : 2018
Publisher : S&P Consulting Pages : 99 Format : PDF
Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults.
In 2017, the global Geriatric Medicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global Geriatric Medicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Geriatric Medicines development in United States, Europe and China.

The key players covered in this study

    Eli Lilly and Company

    AstraZeneca

    Boehringer Ingelheim

    Abbott Laboratories

    Sanofi

    Bristol-Myers Squibb

    Merck

    Novartis

    Pfizer

    GSK

Market segment by Type, the product can be split into

    Analgesics

    Antihypertensives

    Statins

    Antidiabetics

    Proton Pump Inhibitor

    Anticoagulant

    Antipsychotics

    Antidepressants

Market segment by Application, split into

    Cardiovascular diseases

    Arthritis

    Neurological Disorders

    Cancer

    Osteoporosis

    Respiratory

Market segment by Regions/Countries, this report covers

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

    Central & South America

The study objectives of this report are:

    To analyze global Geriatric Medicines status, future forecast, growth opportunity, key market and key players.

    To present the Geriatric Medicines development in United States, Europe and China.

    To strategically profile the key players and comprehensively analyze their development plan and strategies.

    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Geriatric Medicines are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview

    1.1 Study Scope

    1.2 Key Market Segments

    1.3 Players Covered

    1.4 Market Analysis by Type

        1.4.1 Global Geriatric Medicines Market Size Growth Rate by Type (2013-2025)

        1.4.2 Analgesics

        1.4.3 Antihypertensives

        1.4.4 Statins

        1.4.5 Antidiabetics

        1.4.6 Proton Pump Inhibitor

        1.4.7 Anticoagulant

        1.4.8 Antipsychotics

        1.4.9 Antidepressants

    1.5 Market by Application

        1.5.1 Global Geriatric Medicines Market Share by Application (2013-2025)

        1.5.2 Cardiovascular diseases

        1.5.3 Arthritis

        1.5.4 Neurological Disorders

        1.5.5 Cancer

        1.5.6 Osteoporosis

        1.5.7 Respiratory

    1.6 Study Objectives

    1.7 Years Considered

2 Global Growth Trends

    2.1 Geriatric Medicines Market Size

    2.2 Geriatric Medicines Growth Trends by Regions

        2.2.1 Geriatric Medicines Market Size by Regions (2013-2025)

        2.2.2 Geriatric Medicines Market Share by Regions (2013-2018)

    2.3 Industry Trends

        2.3.1 Market Top Trends

        2.3.2 Market Drivers

        2.3.3 Market Opportunities

3 Market Share by Key Players

    3.1 Geriatric Medicines Market Size by Manufacturers

        3.1.1 Global Geriatric Medicines Revenue by Manufacturers (2013-2018)

        3.1.2 Global Geriatric Medicines Revenue Market Share by Manufacturers (2013-2018)

        3.1.3 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI)

    3.2 Geriatric Medicines Key Players Head office and Area Served

    3.3 Key Players Geriatric Medicines Product/Solution/Service

    3.4 Date of Enter into Geriatric Medicines Market

    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

    4.1 Global Geriatric Medicines Market Size by Type (2013-2018)

    4.2 Global Geriatric Medicines Market Size by Application (2013-2018)

5 United States

    5.1 United States Geriatric Medicines Market Size (2013-2018)

    5.2 Geriatric Medicines Key Players in United States

    5.3 United States Geriatric Medicines Market Size by Type

    5.4 United States Geriatric Medicines Market Size by Application

6 Europe

    6.1 Europe Geriatric Medicines Market Size (2013-2018)

    6.2 Geriatric Medicines Key Players in Europe

    6.3 Europe Geriatric Medicines Market Size by Type

    6.4 Europe Geriatric Medicines Market Size by Application

7 China

    7.1 China Geriatric Medicines Market Size (2013-2018)

    7.2 Geriatric Medicines Key Players in China

    7.3 China Geriatric Medicines Market Size by Type

    7.4 China Geriatric Medicines Market Size by Application

8 Japan

    8.1 Japan Geriatric Medicines Market Size (2013-2018)

    8.2 Geriatric Medicines Key Players in Japan

    8.3 Japan Geriatric Medicines Market Size by Type

    8.4 Japan Geriatric Medicines Market Size by Application

9 Southeast Asia

    9.1 Southeast Asia Geriatric Medicines Market Size (2013-2018)

    9.2 Geriatric Medicines Key Players in Southeast Asia

    9.3 Southeast Asia Geriatric Medicines Market Size by Type

    9.4 Southeast Asia Geriatric Medicines Market Size by Application

10 India

    10.1 India Geriatric Medicines Market Size (2013-2018)

    10.2 Geriatric Medicines Key Players in India

    10.3 India Geriatric Medicines Market Size by Type

    10.4 India Geriatric Medicines Market Size by Application

11 Central & South America

    11.1 Central & South America Geriatric Medicines Market Size (2013-2018)

    11.2 Geriatric Medicines Key Players in Central & South America

    11.3 Central & South America Geriatric Medicines Market Size by Type

    11.4 Central & South America Geriatric Medicines Market Size by Application

12 International Players Profiles

    12.1 Eli Lilly and Company

        12.1.1 Eli Lilly and Company Company Details

        12.1.2 Company Description and Business Overview

        12.1.3 Geriatric Medicines Introduction

        12.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2013-2018)

        12.1.5 Eli Lilly and Company Recent Development

    12.2 AstraZeneca

        12.2.1 AstraZeneca Company Details

        12.2.2 Company Description and Business Overview

        12.2.3 Geriatric Medicines Introduction

        12.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2013-2018)

        12.2.5 AstraZeneca Recent Development

    12.3 Boehringer Ingelheim

        12.3.1 Boehringer Ingelheim Company Details

        12.3.2 Company Description and Business Overview

        12.3.3 Geriatric Medicines Introduction

        12.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2013-2018)

        12.3.5 Boehringer Ingelheim Recent Development

    12.4 Abbott Laboratories

        12.4.1 Abbott Laboratories Company Details

        12.4.2 Company Description and Business Overview

        12.4.3 Geriatric Medicines Introduction

        12.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2013-2018)

        12.4.5 Abbott Laboratories Recent Development

    12.5 Sanofi

        12.5.1 Sanofi Company Details

        12.5.2 Company Description and Business Overview

        12.5.3 Geriatric Medicines Introduction

        12.5.4 Sanofi Revenue in Geriatric Medicines Business (2013-2018)

        12.5.5 Sanofi Recent Development

    12.6 Bristol-Myers Squibb

        12.6.1 Bristol-Myers Squibb Company Details

        12.6.2 Company Description and Business Overview

        12.6.3 Geriatric Medicines Introduction

        12.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2013-2018)

        12.6.5 Bristol-Myers Squibb Recent Development

    12.7 Merck

        12.7.1 Merck Company Details

        12.7.2 Company Description and Business Overview

        12.7.3 Geriatric Medicines Introduction

        12.7.4 Merck Revenue in Geriatric Medicines Business (2013-2018)

        12.7.5 Merck Recent Development

    12.8 Novartis

        12.8.1 Novartis Company Details

        12.8.2 Company Description and Business Overview

        12.8.3 Geriatric Medicines Introduction

        12.8.4 Novartis Revenue in Geriatric Medicines Business (2013-2018)

        12.8.5 Novartis Recent Development

    12.9 Pfizer

        12.9.1 Pfizer Company Details

        12.9.2 Company Description and Business Overview

        12.9.3 Geriatric Medicines Introduction

        12.9.4 Pfizer Revenue in Geriatric Medicines Business (2013-2018)

        12.9.5 Pfizer Recent Development

    12.10 GSK

        12.10.1 GSK Company Details

        12.10.2 Company Description and Business Overview

        12.10.3 Geriatric Medicines Introduction

        12.10.4 GSK Revenue in Geriatric Medicines Business (2013-2018)

        12.10.5 GSK Recent Development

13 Market Forecast 2018-2025

    13.1 Market Size Forecast by Regions

    13.2 United States

    13.3 Europe

    13.4 China

    13.5 Japan

    13.6 Southeast Asia

    13.7 India

    13.8 Central & South America

    13.9 Market Size Forecast by Product (2018-2025)

    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

    15.1 Research Methodology

        15.1.1 Methodology/Research Approach

            15.1.1.1 Research Programs/Design

            15.1.1.2 Market Size Estimation

            12.1.1.3 Market Breakdown and Data Triangulation

        15.1.2 Data Source

            15.1.2.1 Secondary Sources

            15.1.2.2 Primary Sources

    15.2 Disclaimer

    15.3 Author Details